The slip
PARKINSON RECEIPTno. 10411
26 Oct 2026, 02:53 UTColigodendrocytes, braak
predictionDOCK10 in oligodendrocytes tracks Braak Lewy-body stage
registered8109971b7a80e0f8
discovery+0.61 p=0.084 n=9
replication-0.20 p=0.615 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.61, p 0.084)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTbb3726abfdbc6e0c3703435a…
follows eb69496b6912…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 10411: DOCK10 in oligodendrocytes, braak
- power
- full sample +0.19 (p 0.460, n 18), 95% CI -0.31 to +0.60. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.14 (p 0.579, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.39 (p 0.107, n 18). could be the mix.
- skeptic
- leave-one-out range +0.09 to +0.33, sign flips 0; without severely affected donors +0.19 (p 0.460, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DOCK10 in oligodendrocytes.
case closed: nothing better to follow up.